EG20543A - Process for preparing of novel antimicrobial -5- (n-heterosubstituted amino) quinolones - Google Patents

Process for preparing of novel antimicrobial -5- (n-heterosubstituted amino) quinolones

Info

Publication number
EG20543A
EG20543A EG68693A EG68693A EG20543A EG 20543 A EG20543 A EG 20543A EG 68693 A EG68693 A EG 68693A EG 68693 A EG68693 A EG 68693A EG 20543 A EG20543 A EG 20543A
Authority
EG
Egypt
Prior art keywords
quinolones
preparing
novel antimicrobial
heterosubstituted amino
heterosubstituted
Prior art date
Application number
EG68693A
Other languages
English (en)
Inventor
Thomas Prosser Demuth Jr
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Application granted granted Critical
Publication of EG20543A publication Critical patent/EG20543A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
EG68693A 1992-10-30 1993-01-30 Process for preparing of novel antimicrobial -5- (n-heterosubstituted amino) quinolones EG20543A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US96896092A 1992-10-30 1992-10-30

Publications (1)

Publication Number Publication Date
EG20543A true EG20543A (en) 1999-07-31

Family

ID=25514997

Family Applications (1)

Application Number Title Priority Date Filing Date
EG68693A EG20543A (en) 1992-10-30 1993-01-30 Process for preparing of novel antimicrobial -5- (n-heterosubstituted amino) quinolones

Country Status (21)

Country Link
EP (1) EP0666853A1 (xx)
JP (1) JPH08502750A (xx)
KR (1) KR950704301A (xx)
CN (1) CN1064357C (xx)
AU (1) AU687018B2 (xx)
BR (1) BR9307347A (xx)
CA (1) CA2148003A1 (xx)
CZ (1) CZ282581B6 (xx)
EG (1) EG20543A (xx)
FI (1) FI952049A (xx)
HU (1) HUT72072A (xx)
IL (1) IL107323A (xx)
MX (1) MX9306814A (xx)
NO (1) NO951640L (xx)
NZ (1) NZ257470A (xx)
PL (1) PL178094B1 (xx)
RU (1) RU2126000C1 (xx)
SG (1) SG59979A1 (xx)
SK (1) SK54795A3 (xx)
WO (1) WO1994010163A1 (xx)
ZA (1) ZA938089B (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5646163A (en) * 1992-10-30 1997-07-08 The Procter & Gamble Company Quinolone 5-(N-heterosubstituted amino) antimicrobials
ATE190972T1 (de) * 1994-08-02 2000-04-15 Procter & Gamble Verfahren zur herstellung von antimikrobiellen verbindungen
EP0775145A1 (en) * 1994-08-02 1997-05-28 The Procter & Gamble Company Process for making quinolonyl lactam antimicrobials and novel intermediate compounds
CA2242242C (en) * 1996-02-09 2001-08-07 Toyama Chemical Co., Ltd. Quinolonecarboxylic acid derivatives or salts thereof
US8524734B2 (en) 2005-05-18 2013-09-03 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
PT1901749T (pt) * 2005-05-18 2016-11-04 Raptor Pharmaceuticals Inc Fluoroquinolonas aerossolizadas e suas utilizações
EE05697B1 (et) 2005-06-08 2014-02-17 Janssen Pharmaceutica N.V. Kinoliini derivaadid kui antibakteriaalsed toimeained
EA010601B1 (ru) * 2005-06-09 2008-10-30 Янссен Фармацевтика Н.В. Производные хинолина в качестве антибактериальных агентов
CN101020647B (zh) * 2007-02-14 2011-03-30 杭州师范学院 一种β-环丙胺基丙烯酸(酯)的合成方法
US8063066B2 (en) 2007-03-19 2011-11-22 Takeda Pharmaceutical Company Limited MAPK/ERK kinase inhibitors
DK3092901T3 (da) * 2007-10-05 2020-05-18 Senhwa Biosciences Inc Quinolonanaloger og fremgangsmåder relateret dertil
MX2010012855A (es) * 2008-06-03 2010-12-21 Actelion Pharmaceuticals Ltd Derivados de [4-(1-amino-etil)-ciclohexil]-metil-amina y [6-(1-amino-etil)-tetrahidro-piran-3-il]-metil-amina como antibacterianos.
ES2809177T3 (es) 2008-10-07 2021-03-03 Horizon Orphan Llc Inhalación de levofloxacino para reducir la inflamación pulmonar
JP2012505223A (ja) 2008-10-07 2012-03-01 エムペックス・ファーマシューティカルズ・インコーポレーテッド 薬物動態の改善のためのエアゾールフルオロキノロン配合物
AR076222A1 (es) * 2009-04-09 2011-05-26 Actelion Pharmaceuticals Ltd Derivados 2-hidroxietil-1h-quinolin-ona y sus analogos azaisotericos con actividad antibacteriana y composiciones farmaceuticas que los contienen
CA2773033C (en) 2009-09-04 2016-10-11 Mpex Pharmaceuticals, Inc. Use of aerosolized levofloxacin for treating cystic fibrosis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4668680A (en) * 1985-12-12 1987-05-26 Warner-Lambert Company 5-amino-6,8-difluoroquinolones as antibacterial agents
JPH0228178A (ja) * 1988-04-23 1990-01-30 Toyama Chem Co Ltd 新規なピリドンカルボン酸誘導体およびその塩並びにそれらの製造法
DE3906365A1 (de) * 1988-07-15 1990-01-18 Bayer Ag 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe
IE66202B1 (en) * 1989-08-16 1995-12-13 Pfizer Azabicyclo quinolone carboxylic acids
JPH05506033A (ja) * 1990-04-18 1993-09-02 ノーウィッチ、イートン、ファーマスーティカルズ、インコーポレーテッド 抗微生物性キノロニルラクタム類
WO1992009596A1 (en) * 1990-11-30 1992-06-11 Warner-Lambert Company Individual stereoisomers of 7-[3-(1-aminoalkyl)-1-pyrrolidinyl]-quinolones and naphthyridones as antibacterial agents

Also Published As

Publication number Publication date
MX9306814A (es) 1994-07-29
CA2148003A1 (en) 1994-05-11
ZA938089B (en) 1994-06-07
SK54795A3 (en) 1995-12-06
BR9307347A (pt) 1999-05-25
HUT72072A (en) 1996-03-28
PL178094B1 (pl) 2000-02-29
NZ257470A (en) 1997-08-22
KR950704301A (ko) 1995-11-17
NO951640D0 (no) 1995-04-28
AU687018B2 (en) 1998-02-19
SG59979A1 (en) 1999-02-22
IL107323A (en) 2000-06-01
FI952049A0 (fi) 1995-04-28
RU95110762A (ru) 1997-01-10
CN1064357C (zh) 2001-04-11
JPH08502750A (ja) 1996-03-26
NO951640L (no) 1995-06-30
IL107323A0 (en) 1994-01-25
WO1994010163A1 (en) 1994-05-11
FI952049A (fi) 1995-04-28
CN1092773A (zh) 1994-09-28
EP0666853A1 (en) 1995-08-16
HU9501237D0 (en) 1995-06-28
RU2126000C1 (ru) 1999-02-10
CZ282581B6 (cs) 1997-08-13
CZ109795A3 (en) 1995-12-13
AU5409794A (en) 1994-05-24
PL308671A1 (en) 1995-08-21

Similar Documents

Publication Publication Date Title
HU9501973D0 (en) Process for preparing quinoline amines
SG55048A1 (en) Process for preparing 2-para-dioxanones
EP0514692A3 (en) Process for the preparation of amines
GB2297255B (en) Process for preparing phencynonate hydrochloride of alpha configuration
EP0582201A3 (en) Process for the preparation of glycerincarbonate
EG20543A (en) Process for preparing of novel antimicrobial -5- (n-heterosubstituted amino) quinolones
IL98095A0 (en) Process for preparing peptide
EP0551916A3 (en) Process for stabilisation of proteins
HU9401695D0 (en) Process for preparation of amines from aldehydes
GB9114734D0 (en) Process for modifying proteins
EP0560109A3 (en) Process for the preparation of 1-fluorocyclopropyl-methyl-ketone
GB9323088D0 (en) Novel process for the preparation of benzylformimidate
HUT67641A (en) Process for preparation of difluoromethoxy- and difluoromethylthioarenes
EP0457730A3 (en) Process for preparation of thioderivatives of alkylhydroxyanilinotriazine
EP0573874A3 (en) Process for the preparation of beta-naphthylbenzylether
HUT65321A (en) Process for preparation of-n-acylated-p-phends
EP0560127A3 (en) Process for the preparation of cycloaliphatic amines
HU9303010D0 (en) Process for preparation of 2-methyl-thiazole-5-carboxylates
EG20289A (en) Process for preparing of novel pharmaceutical compositions comprising 3- substituted 2-oxindole -1- corboximides
ZA935657B (en) Process for the preparation of imidazypyridines
GB2275266B (en) Process of preparing 2-methyl-3-aminobenzotrifluoride
HU9401118D0 (en) Process for preparation of 4-alkane-aryl-benzylethers
EP0422366A3 (en) Process for the preparation of n-substituted pyrolidin-2-ones
EP0547414A3 (en) Process for the preparation of n-substituted nitro-p-phenylenediamines
HU9401981D0 (en) Process for preparation of chloro-methyl-pyridin derivatives